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especially for clients post-stroke. Most therapists are not aware of, nor do they utilize specific assessments for,
medication management capacity. The purpose of this pilot study was to compare the results of the
ManageMed Screen (MMS), the Screening for Self-Medication Safety Post Stroke (S5), and the Montreal
Assessment of Cognition (MoCA) on a population of rehabilitation clients post-stroke to determine the
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occupational therapy practice among other healthcare professions: the MMS was validated for the general
adult population, the S5 for clients post-stroke, and the MoCA is a cognitive screen used with adult clients
with a variety of diagnoses including stroke. The MoCA was used to explore the potential relationship
between cognition and medication management capacity. Study participants included five clients post-stroke
and three occupational therapists. Clients were screened by the occupational therapists with the MMS, S5,
and MoCA, and clinicians also participated in a focus group to assess their perceived usefulness of the screens.
Results demonstrated that the MMS score compared to the S5 score was not statistically significant (r=.671,
p=.215). There is no established consistency between the MoCA and MMS given these five clients. The MMS
score was correlated to the MoCA score and was not found to be significant at a value of .205 with p=.741.
The S5 score was also correlated to the MoCA score using SPSS and was found to have a non-significant value
of -.287 and p=.640. Additionally, through a focus group, clinicians deemed both the MMS and S5 as useful,
but felt the MMS was a more useful screen for their clinical practice with regard to efficient and practical use
with clients post-stroke in a rehabilitation setting.
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ABSTRACT  
Occupational therapists need to efficiently and accurately screen a client’s medication management capacity, especially for 
clients post-stroke. Most therapists are not aware of, nor do they utilize specific assessments for, medication management 
capacity. The purpose of this pilot study was to compare the results of the ManageMed Screen (MMS), the Screening for Self-
Medication Safety Post Stroke (S5), and the Montreal Assessment of Cognition (MoCA) on a population of rehabilitation clients 
post-stroke to determine the usefulness of the medication assessment tools in clinical practice. These screens were designed for 
use in occupational therapy practice among other healthcare professions: the MMS was validated for the general adult 
population, the S5 for clients post-stroke, and the MoCA is a cognitive screen used with adult clients with a variety of diagnoses 
including stroke. The MoCA was used to explore the potential relationship between cognition and medication management 
capacity. Study participants included five clients post-stroke and three occupational therapists. Clients were screened by the 
occupational therapists with the MMS, S5, and MoCA, and clinicians also participated in a focus group to assess their perceived 
usefulness of the screens. Results demonstrated that the MMS score compared to the S5 score was not statistically significant 
(r=.671, p=.215). There is no established consistency between the MoCA and MMS given these five clients. The MMS score was 
correlated to the MoCA score and was not found to be significant at a value of .205 with p=.741. The S5 score was also 
correlated to the MoCA score using SPSS and was found to have a non-significant value of -.287 and p=.640. Additionally, 
through a focus group, clinicians deemed both the MMS and S5 as useful, but felt the MMS was a more useful screen for their 
clinical practice with regard to efficient and practical use with clients post-stroke in a rehabilitation setting.  
 
INTRODUCTION 
The capacity for medication management is of eminent concern for health professionals as there is an increase in chronic 
disease and medication dependency among older adults.10,12 Poor medication management is related to an increased number of 
medication errors, hospital admissions, and higher mortality rates in the older adult and those with chronic health issues, such as 
stroke.6,7 Medication management capacity is the result of intact higher level cognitive skills which enable a person to be 
independent and safe with this set of activities of daily living (ADL) and instrumental activities of daily living (IADL) tasks. 
Occupational therapists are charged with assessing medication management capacity as it can impact independence and safety 
with daily functioning.  
 
Best practice in occupational therapy would indicate the use of comprehensive and psychometrically strong tools for client 
assessment when available.1 In current practice, specifically in the rehabilitation setting, one often will find clinicians using clinical 
inference from observation of ADLs or “home grown” screens or questionnaires to assess medication management capacity 
rather than standardized assessments.11 Health professionals, such as occupational therapists, are not necessarily accurate at 
predicting a client’s ability with medication management based on observation; functional ability of this task is not always 
detected in routine assessments or observations.6 Wales et al found that occupational therapists often do not use standardized 
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assessment in practice due to their lack of readiness or skill, time commitments, “motivation, self-confidence, lack of support 
from management, personal values and beliefs and lack of knowledge” or awareness of the availability of assessments (p. 2).16 
Clinical judgment about performance of functional tasks, such as medication management, when completed in an unstructured 
and non-standardized manner, leads to decreased legitimacy and limited contributions to evidence-based outcomes in 
occupational therapy.5,6 Using standardized and normed instruments in clinical practice can assist with efficiency and 
documentation of changes in status, and improves overall effectiveness of occupational therapy practice.4 However, the 
approach to medication management capacity screening traditionally has not been standardized in occupational therapy, most 
likely due to lack of awareness of available screens and/or non-availability of screens for a specific population, such as clients 
post-stroke.  
 
There are about a dozen screens in the open market labeled as medication management capacity screens; however, upon 
further review of these screens, many are not appropriate for use with clients post-stroke as they lack research on this 
population, and components within the screen that assess cognitive and physical skills of clients post-stroke are lacking 
(Appendix A). The literature also indicates that assessing cognition alone does not equate to an accurate screen for medication 
management capacity, and for clients post-stroke, physical performance must also be assessed.3 Some of the screens only 
address cognition. Furthermore, many of these screens are profession specific (not occupational therapy), diagnosis specific (not 
stroke), or do not measure medication capacity, but rather adherence patterns.  
 
It would be beneficial for occupational therapists to have a means to efficiently and accurately screen a client’s medication 
management capacity, especially for clients post-stroke. Most therapists are not aware of, nor do they utilize, specific 
assessments for medication management capacity, partly due to lack of readily available fitting assessments. The purpose of this 
study was to determine the capacity to follow a medication routine based on a client’s cognitive and physical performance (not 
their choice to adhere to their own prescribed medication routine). For a client post-stroke, the ability to manage medications can 
be impacted by changes in communication skills, physical abilities, cognition, behavior, sensation, and visual-perception.8 Up to 
65% of stroke survivors demonstrate changes in cognitive function including attention deficits, memory deficits, and spatial 
neglect, all of which can impact functional recovery and safety with medication management.3,17 To ensure clients post-stroke 
have the physical and cognitive skills for safe medication management, screens that assess these skills and are valid and 
reliable for this population are needed.  
 
Two medication management screens have been developed and were found to be appropriate for use in occupational therapy 
practice: the ManageMed Screen (MMS) and the Screening for Self-Medication Safety Post Stroke (S5).8,12 The MMS and S5 
were developed and meet the need for occupational therapists by addressing cognitive and physical performance skills required 
for medication management. The MMS was specifically developed by occupational therapists for assessing medication 
management in the general adult population by health professionals; it was found to be able to differentiate between adults who 
need assistance and those who are independent with this task.12 The MMS is standardized and has undergone validation studies 
as well.12 The S5 was developed by occupational therapists for health professionals to assess medication management capacity 
for clients post-stroke.8 The S5 has undergone one pilot test by its authors for use with adult clients post-stroke; thus, the S5 has 
limited data to support its reliability and validity. These screens continue to need clinical research to support their use in specific 
client populations such as stroke. In a rehabilitation setting for clients post-stroke, clinicians need at least one practical screen 
that will accurately and efficiently assess each client’s cognitive and physical skills required to manage their medications.  
 
The Montreal Cognitive Assessment (MoCA) assesses the clients’ cognition and explores the relationship of cognition and 
medication management capacity. The MoCA is a performance-based screen to assess cognitive skills which contains 16 test 
items that examine attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual 
thinking, calculations, and orientation.9 The MoCA has undergone several years of research and study findings have consistently 
demonstrated excellent validity and reliability.15 
 
RESEARCH QUESTIONS 
1. Is there a correlation between the ManageMed Screen (MMS) and the Screening for Self-Medication Safety Post-Stroke Scale 
(S5) scores for assessing capacity in medication management?  
2. Is there a correlation between the ManageMed Screen (MMS) and the Screening for Self-Medication Safety Post Stroke Scale 
(S5) scores compared to the Montreal Cognitive Assessment (MoCA) for assessing cognition as an indicator for capacity in 
medication management? 
3. Which of the medication management screening tools (or aspects of each screen) offer the most clinically relevant information 
to help inform decision making for treatment and discharge planning for medication management capacity for occupational 
therapy practitioners? 
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METHODOLOGY 
This pilot study used quantitative and qualitative methodologies to begin to determine the usefulness of two fairly new medication 
management screens for use in occupational therapy practice. The scores of the ManageMed Screen (MMS), the Screening for 
Self-Medication Safety Post Stroke (S5), and the Montreal Assessment of Cognition (MoCA) were compared on a population of 
rehabilitation clients post-stroke to determine their usefulness in clinical practice. Part I of the study included five clients post-
stroke and three occupational therapists. Clients were screened by the occupational therapists with the MMS, the S5, and the 
MoCA. Part II consisted of the clinicians who participated in a focus group to assess their perceived usefulness of the screens 
from part I.  
 
PARTICIPANTS 
Clinician and client participants were recruited from New England Rehabilitation Hospital Portland, an inpatient rehabilitation 
hospital in Maine. Institutional Review Board approval for this project was obtained from Nova Southeastern University. 
Clinicians included one male and two females with clinical experience ranging from 3 to 15 years. Five clients participated in the 
study, including three females and two males with a mean age of 72.6 years. The post stroke clients were 72 hours from 
discharge, had a diagnosis of stroke, scored a 4 or greater on the Functional Independence Measure for cognition, and were 
able to speak and read English. Twenty percent of client participants had a right hemispheric stroke of embolic origin, days post-
stroke ranged from 9 to 17 with a mean of 11.6 days, and clients were taking medications ranging from 4 to 13 medications with 
an average of 9.8 medications at the time of screen administration. 
 
INSTRUMENTATION 
The ManageMed Screen (MMS) has 30 questions and performance tasks to assess “reading, medication knowledge base, 
problem solving, short-term and prospective memory, and calculations” (p. 2).13 The MMS is standardized and has evidence of 
adequate validity and reliability. A sample question for reading, medication knowledge base, and problem solving is “If this 
[prescription vial A] were a prescription from your doctor, would it be safe to take?” The client is given a prescription bottle with 
printed label information to review; the client is to note the date the medication expired. Other questions related to problem-
solving, short-term memory, calculation, and physical skills include “Can you open this container? Open it and count the number 
of pills. How long will these pills last if taken as prescribed?” Lastly, one IADL task in particular requires the client to successfully 
utilize higher level cognitive skills and assesses physical skills when the client is asked to set up a pill organizer using the three 
medications based on instructions on each prescription bottle while recalling that their meals are taken at 8:00am, noon and 
5:30pm. Slots in a plastic organizer must be opened and the client is asked to put in the correct number of pills at the correct 
times. Performance on the MMS is scored on a 0 or 1 scale for each item, with 0 indicating unable to perform or performed 
incorrectly and 1 as performed correctly. The maximum score one can obtain is 39 points; the client’s score can then be 
compared to age-related norms developed by the authors through previous research.  
 
Potential impairments that can be distinguished with the use of this screen include decreased vision, decreased prospective 
memory, decreased recognition, decreased safety awareness, decreased attention to detail, decreased physical ability, 
decreased calculation skills, decreased retrospective memory, decreased organizational skills, and decreased insight.13 The 
findings of these impairments could indicate poor medication management capacity and also provide areas for the occupational 
therapist to focus on either through rehabilitation or remediation intervention strategies.  
 
The Screening for Self-Medication Safety Post Stroke (S5) has a checklist of 16 questions to assess basic orientation, the 
manipulation of medication bottles, calculating medication doses, immediate and delayed memory recall tasks, manipulating a 
syringe (if appropriate for the client), completing visual recognition and visual spatial tasks, and problem-solving questions to 
assess cognition (orientation; immediate and delayed memory recall), communication (comprehension; reading), motor function, 
visual-perception, and judgment/executive functions/self-efficacy.8,14 A sample question which addresses calculation, visual 
recognition, and problem solving includes, “If you have to take 2 pills in the morning and 2 at night, show me how you would 
group the pills.” This is stated after providing the client an open bottle with 8 identical white disc-shaped pills. To assess physical 
skills, some test items include providing a syringe without a needle and asking the client to demonstrate how to inject their 
medications or providing the client with a bottle of liquid medication and asking them to “Open the bottle and pour out 10ml of the 
liquid into this cup.” Scoring is completed by indicating if the task was done correctly by checking the Yes or No boxes beside 
each question. The score is out of 16 questions; in general, a higher score of more “Yes” responses would indicate less difficulty 
with medication management. More importantly, the screen offers specific areas of concern (when a question is marked as “No”) 
that may be able to be addressed in occupational therapy intervention. Scoring criteria was not developed beyond a yes/no 
checklist. For the purpose of this study as developed by the primary investigator, questions marked “yes” were counted as 1 
point. If a client scored a 14, 15 or 16 on the S5, this was deemed “normal” performance capacity. If a client scored 10 to 13, this 
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was equated to “questionable” performance capacity, and if a client scored 9 or less, this was equated to a “poor” performance 
capacity with medication management. 
 
The Montreal Cognitive Assessment (MoCA) contains 16 test items that examine attention and concentration, executive 
functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.9 A sample question 
from version 2 to assess attention, concentration, executive function, visuoconstructional skills, and conceptual thinking is 
drawing a clock. The client is asked to draw a clock, place all numbers in the clock and set the time to five past four.9 The client 
is scored based on contour of the clock, correct sequence, and placement of numbers in the clock along with correct placement 
of the hands of the clock. Points are given based on correct answers/performance of task. Clinician participants were trained by 
the primary investigator for all three assessments, and inter-rater reliability was established by comparing scores on a simulated 
client.  
 
In part II of the study, the instrument used in the guided focus group for clinician participants was an open-ended interview guide 
of 10 questions devised by the primary investigator. The questions used engagement and exploration questions to elicit feedback 
on administration of the screens as suggested by Creswell.2 The semi-structured questions were intended to evoke dialogue 
among the clinicians and to solicit feedback regarding their impression of the screens, the value of information obtained from 
testing, advantages or disadvantages of each screen, scoring discrepancies or questions, and overall usefulness the screens. A 
sample question included, “Share your impression or feedback on the administration of each test, such as ease of setup, clarity 
of instructions, items in test kits, questions asked etc.”  
 
Data Collection Part I 
Data collection lasted 6 weeks for a minimum of a sample of convenience of five client participants. Clients were selected 
following the inclusion criteria and consented to participate. Clinicians gathered data in order of the questions as listed on the 
data collection sheets. Information such as age, gender, hand dominance, stroke location/type, days post-stroke, medication 
questions, presence of visual impairment, and ratings for stress and sleep were always completed first and in numerical order. 
The screens were given in random order for each client. 
 
Data Collection Part II     
After the clinicians completed a minimum of five assessments and after six weeks from the start of data collection, the clinicians 
participated in a 1 hour and 30 minute focus group interview. The interview was transcribed verbatim by hand by the primary 
investigator during the interview process. The primary investigator facilitated the discussion with the focus on clinician feedback 
on administration of each screen (ease, setup, instructions etc.), value of data obtained from the screens, advantage/ 
disadvantage of each screen, and usefulness of the screens to clinical practice. 
 
Data Part I 
As seen in Table 1, compared to the normative scores by age, client 1 scored within one standard deviation above the mean 
score for the MMS, “normal” performance on the S5, and below the mean score for the MoCA. Client 2 scored well above one 
standard deviation of the mean score for the MMS, “normal” performance on the S5, and above the mean score for the MoCA. 
Client 3 scored within one standard deviation below the mean score on MMS, “questionable” performance on the S5, and at the 
mean for the MoCA. Client 4 scored within one standard deviation below the mean score for the MMS, “normal” performance on 
the S5, and below the mean for the MoCA. Client 5 scored within one standard deviation above the mean score for the MMS, 
“normal” performance on the S5, and at the norm for the MoCA.  
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Table 1. Client Scores on MMS, S5, and MoCA 
Client MMS 
(mean mean +/- SD*) 
S5** MoCA*** 
1 30 
(29 +/- 3.39) 
15 21 
2 35 
(29 +/- 3.39) 
15 28 
3 26 
(29 +/- 3.39) 
13 26 
4 32 
(34 +/- 3.29) 
15 19 
5 31 
(29 +/- 3.39) 
14 26 
*MMS age norms based on client age +/- standard deviation (SD)13 
**S5:14, 15 or 16 = ‘normal’ performance capacity;  
10 to 13 = ‘questionable’ performance capacity;  
9 or less = ‘poor’ performance capacity8 
***MoCA: 26 or better = normal performance9 
 
RESULTS PART 1 
Using visual comparison of data and statistical data analysis presented in the above sections, the question, “How consistent are 
the ManageMed Screen (MMS) and the Screening for Self-Medication Safety Post Stroke Scale (S5) scores for assessing 
capacity in medication management?” can be answered by reviewing data in Table 2. Overall, all clients scored within their age 
norms on the MMS, and all but client 3 scored “normal” performance capacity on the S5. Using the Statistical Package for Social 
Sciences (SPSS – version 20), each test score was correlated using nonparametric two-tailed test of Spearman’s rho 
correlations. The MMS score was compared to the S5 score and was found to be statistically non-significant (r=.671, p=.215).  
 
           Table 2. Score Comparison of the MMS and S5 
Client MMS Score 
(mean score +/- SD)* 
S5 Score** 
1 30 
(29 +/- 3.39) 
15 
2 35 
(29 +/- 3.39) 
15 
3 26 
(29 +/- 3.39) 
13 
4 32 
(34 +/- 3.29) 
15 
5 31 
(29 +/- 3.39) 
14 
*MMS age norms based on client age +/- standard deviation (SD)13 
**S5:14, 15 or 16 = ‘normal’ performance capacity;  
     10 to 13 = ‘questionable’ performance capacity;  
     9 or less = ‘poor’ performance capacity8 
 
When comparing the client’s performance on the MMS to the S5, the clients who scored the highest on the MMS also scored 
highest on the S5 (e.g. Clients 2 and 4 in Table 2). However, this pattern is not consistent as clients 1, 3, and 5 also performed 
within the norm on the MMS and clients 1 and 5 scored 14 or 15 on the S5 suggesting “normal” performance capacity. 
Nonetheless, client 3 who scored the lowest on the MMS (but still within age norms) also scored the lowest on the S5 
(“questionable” performance capacity). This pattern does not suggest a true pattern of consistency between the MMS and S5 
scores.  
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To answer the second research question, “Is there a correlation between the ManageMed Screen (MMS) and the Screening for 
Self-Medication Safety Post Stroke Scale (S5) scores compared to the Montreal Cognitive Assessment (MoCA) for assessing 
cognition as an indicator for capacity in medication management?” the data are presented in Table 1. 
 
When comparing client scores from the MMS and the MoCA, there is no established consistency between the MoCA and MMS 
given these five clients.  
 
When comparing the MoCA to the S5, clients 1 and 5 who scored below norms on the MoCA scored within “normal” performance 
on the S5; conversely, client 3 who scored “questionable” performance on the S5 scored at the norm on the MoCA. There does 
not appear to be a consistent relationship between the S5 and the MoCA.  
 
Using Statistical Package for Social Sciences (SPSS – version 20), the test scores for the MMS and MoCA were correlated using 
nonparametric two-tailed test of Spearman’s rho correlations. The MMS score was correlated to the MoCA score and was not 
found to be significant at a value of .205 with p=.741. The S5 score was also correlated to the MoCA score using SPSS and was 
found to have a non-significant value of -.287 and p=.640.  
 
From the comparison of the both the MMS and S5 to the MoCA for consistency of scoring, there is not a consistent relationship 
with scores for medication management capacity and cognition. Normal performance based on norms of the MMS does not 
necessarily indicate “normal” performance on the MoCA, much like “normal” performance on the S5 does not indicate “normal” 
performance on the MoCA. Any relationships noted must be interpreted with the utmost caution due to the pilot nature of this 
study.  
 
DATA PART II  
Thematic qualitative analysis from the transcribed focused group data was completed for data analysis of part II. Thematic 
analysis of all 10 questions and answers led to the development of general themes that enables this data presentation. Theme A 
entails clinician feedback on usefulness of the screens via administration, ease of setup, clarity of instructions, test kit 
assembly/use, and advantages/disadvantages of each screen. Theme B relates the use of the screens in clinical practice via the 
value of the data collected for treatment planning and discharge recommendations, and clinicians’ impression with the screen’s 
ability to differentiate adequate from inadequate medication management skills. Theme C relates to the clinicians preference of 
screen for future use and the subjects’ responses to testing.  
 
RESULTS PART II 
The three clinicians’ consensus revealed that they felt the MMS was the more useful screen for medication management when 
comparing advantages and disadvantages in regards to accuracy, efficiency, practicality, and clinical relevance. This directly 
answers the third research question, “Which of the medication management screening tools (or aspects of each screen) offers 
the most clinically relevant information to help inform decision making for treatment and discharge planning for medication 
management capacity for occupational therapy practitioners?” While the MMS took the longest to administer, previously 
mentioned advantages appear to make it the most clinically useful tool for clients post-stroke in this setting when compared to 
the S5 and MoCA. The MMS offers more clinically relevant information by screening visual, cognitive, and physical performance 
skills by having clients read medication information and pill bottles, manipulate pill bottles and pills, and complete memory and 
problem solving tasks. The IADL component of filling of the pill organizer of the MMS was the most revealing in terms of where 
clients could have difficulty with managing a complex medication routine. However, it was also this component that was the most 
challenging for clinicians to administer and score.  
 
Clinicians also felt that they would adopt the use of the MoCA in their clinical practice, but not as a medication management 
capacity screen. The MoCA provides clinically relevant information as it can detect what areas of cognition are challenges for the 
client (visuospatial/executive, naming, memory, attention, language, abstraction, and/or orientation). The use of the MoCA can 
target treatment towards compensation or remediation approaches addressing the identified deficits. Additionally, the MoCA is 
well understood by the other interprofessional team members and can create a dialogue during team rounds to ensure the client 
is receiving the necessary services while in rehabilitation.  
 
The S5 was the least likely of the screens to be frequently used by these clinicians as it currently lacks usefulness and clinically 
relevant information. The S5 was found to be too subjective, vague and the overall score does not relate to a norm. Generally, 
clinicians felt that while the S5 was the quickest and simplest screen to administer, it did not yield data with enough depth to be 
useful. Clinicians did appreciate that a variety of pill sizes, colors, and pill or liquid bottles were included in the screen, but the 
score was not viewed as meaningful. The S5 will continue to be a possible tool that clinicians can offer a client should the MMS 
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be too challenging or if the client is resistive to the screening process. This qualitative, thematic analysis based on clinician 
feedback suggests that overall, the MMS offers the most clinically useful and relevant information for treatment and discharge 
planning.  
 
DISCUSSION 
Best practice would indicate the use of comprehensive and psychometrically strong tools for client assessment; clinicians often 
choose assessments tools based on their usefulness and practicality to their practice.1 From the literature, clinicians were made 
aware of several medication management screens available on the market for use in practice. However, clinicians were also 
informed of key items that should be included in a medication management screen, such as language abilities, reading and 
writing skills, numeric/calculation capabilities, limb praxis, visuospatial function, social use of language, emotional function, 
attention, executive function, memory, and observation of performance of medication management tasks from the literature of 
Donovan et al and Robnett et al.3,12 When comparing these key items to current assessments, the only medication management 
capacity screens remaining that fit these criteria were the MMS and S5. The MMS and S5 were chosen for further study because 
of their content and format that included cognitive and physical assessments.  
 
The results from this pilot study have introduced data for the ManageMed Screen and the Screening for Self-Medication Safety 
Post Stroke for assessing medication management capacity for clients post-stroke. While statistical significance of scores 
between the MMS and S5 was not obtained, cognition is one construct in medication management capacity that can be 
assessed with the MoCA which enables the clinician to determine what area of cognition may be impacting performance with 
medication management.  
 
The second focus of the study utilized qualitative analysis of clinician responses for the usefulness of the medication 
management screens in clinical practice. General consensus is that occupational therapy practitioners preferred the use of MMS 
due to the depth and breadth of information the screen was able to provide. This information aids clinical practice regarding client 
safety with medication management. Clinicians did state that the cost of the kit to their department was not a deterrent to 
obtaining and using this kit. Overall, clinicians indicated in their responses that the MMS offered the most useful information to 
inform their practice for clients post-stroke as it assesses “reading, medication knowledge base, problem solving, short-term and 
prospective memory, and calculations, and lastly performance,” all crucial to safety and independence in the realm of medication 
management13.  
 
In current practice, occupational therapists are often not using standardized assessment for assessing medication management 
capacity in the rehabilitation setting. “Homegrown” assessments lack reliability and validity, and using assessments designed for 
other professions does not measure occupational therapy outcomes.5,11 Occupational therapy practitioners need to adopt new, 
valid, reliable, easily administered, and client-friendly tools to strive for professional excellence and effectiveness.4  
 
This pilot study does give merit and cause for on-going research of this nature. The clinician comments indicate that there is a 
difference in client performance and utility for each screen. A research study with a greater sample size conducted over a longer 
period of time could yield data that has more statistical significance. Further research is needed on the general topic of 
medication management capacity in occupational therapy. Additionally, further research is needed on the use of medication 
management screens for clients post-stroke.  
 
STUDY LIMITATIONS 
A number of limitations must be considered in the interpretations of this pilot study’s findings. First, the sample size for clients 
was small (N = 5), and even smaller for clinicians (N=3). Because of the small sample size of clients, some clinicians only 
conducted the screens on one client; therefore, the depth of information provided in the focus group was limited. Additionally, the 
focus group was not audio recorded, which could have resulted in some loss of meaning or key phrases provided by clinicians.  
 
Furthermore, the data collected on each screen was only a score; therefore, the content of each test item could not be further 
analyzed. The S5 screen did not publish norm values to which the overall score could be related, thus leaving the value of the 
score open to subjective interpretation. Results therefore cannot be generalized, and strong conclusions regarding comparisons 
between screens cannot be made.  
 
Finally, authors of the S5 have indicated a newer version of the S5 is under study, and literature will be made available soon to 
the public. Researchers should review the literature and research for this newer version and utilize it in future studies. Future 
studies should include more client participants to enable clinicians to conduct screening on more than one client for more in 
depth data.  
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Appendix A.  Sample of Medication Management Assessments 
Assessment Description 
Self-Administration of Medication (SAM) Questionnaire, used by nurses to assess a person’s competence to 
self-administer medications 
Medication Management Ability Assessment (MMAA) Used with clients with schizophrenia, assessment in completed 
through role-play 
Drug Regimen Unassisted Grading Scale (DRUGS) Assesses a highly functioning older adult’s ability for self-
medication by looking at ability to identify, access, dose and time 
their personal medication routine 
Medication Management Instrument for Deficiencies in 
the Elderly (MedMaIDE) 
Used for assessment of compliance and management of 
medication routine 
Medication Management Tasks (MMT) Developed for assessment of adaptive strategies in patients with 
dementia 
MedTake Test (MT) Assesses understanding of dosage, indications, schedule, and 
safety through interview of older adults 
Self-Medication Assessment Tool (SMAT) Used by pharmacists to assess deficits in self-management of 
medications by looking at function, cognition, self-reported 
adherence, medication recall  
(Adapted from Kaizer et al., 2010) 
